This inventor holds 1 USPTO granted patent. Top assignee: Hexal Pharmaceuticals, Inc.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Aggelos Nikolopoulos: Innovator in Pharmaceutical Chemistry
Introduction
Aggelos Nikolopoulos is a notable inventor based in Bayreuth, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of ranitidine hydrochloride.
Latest Patents
Nikolopoulos holds a patent for a process titled "Process for preparing form 1 ranitidine hydrochloride." This innovative method involves preparing pure N-[2-[[[5-[dimethylamino)-methyl-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethyldiamine hydrochloride, designated as Form 1 ranitidine hydrochloride. The process utilizes ranitidine in methylene chloride with the addition of hydrochloric acid. The resulting Form 1 ranitidine hydrochloride is stable and suitable for producing commercial-scale quantities.
Career Highlights
Aggelos Nikolopoulos is currently employed at Hexal Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the stability and usability of pharmaceutical compounds.
Collaborations
Nikolopoulos collaborates with Helmut Schickaneder, contributing to the innovative environment at Hexal Pharmaceuticals.
Conclusion
Aggelos Nikolopoulos is a prominent figure in pharmaceutical innovation, with a focus on improving the preparation processes of essential compounds. His contributions are vital for the advancement of pharmaceutical chemistry and the production of stable medications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile